Search - tctmd.com

Displaying 381 - 400 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

TCT 1611: Trialign: Transcatheter Repair of the Tricuspid Valve

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Nadira Hamid

October 30, 2016

Presentation TCT 2016

Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Apostolos Tzikas

October 30, 2016

Presentation TCT 2016

Transcatheter Valve-in-Valve Therapy: Clinical and Technical Pearls

Presenter: A. Pieter Kappetein, Allan Schwartz, Vinayak Bapat

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Presenter: Charles J. Davidson, Nicole Ibrahim, Paul Sorajja

October 30, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

Presenter: A. Pieter Kappetein, Allan Schwartz, Danny Dvir

October 30, 2016

Presentation TCT 2016

How Good Can Surgical Outcomes Be in Secondary MR?

Presenter: Michael J. Mack, Francesco Maisano, Michael Argenziano

October 30, 2016

Presentation TCT 2016

TCT 1600: Minimally Invasive Mitral Valve Replacement With Sapien S3 Valve in a Patient With Severe MAC

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Deborah Tabachnick

October 30, 2016

Presentation TCT 2016

Appropriate Use Criteria of LAA Closure Devices: PMDAs View

Presenter: Mitchell W. Krucoff, Shigeru Saito, Sara Takahashi

October 30, 2016

Presentation TCT 2016

FDA Perspectives

Presenter: Charles J. Davidson, Nicole Ibrahim, John C Laschinger

October 30, 2016

Presentation TCT 2016

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Presenter: A. Pieter Kappetein, Allan Schwartz, Mathew Williams

October 30, 2016

Presentation TCT 2016

Applying Lessons From the CTSN to Clinical Practice

Presenter: Michael J. Mack, Francesco Maisano

October 30, 2016

Presentation TCT 2016

Appropriate Use Criteria of LAA Closure Devices: FDAs View

Presenter: Mitchell W. Krucoff, Shigeru Saito, Rachel Neubrander

October 30, 2016

Presentation TCT 2016

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith

October 30, 2016

Presentation TCT 2016

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr.

October 30, 2016

Presentation TCT 2016

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

Presenter: A. Pieter Kappetein, Allan Schwartz, Lars Sondergaard

October 30, 2016

Presentation TCT 2016

TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension

Presenter: Irene M. Lang, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Appropriate Use Criteria of LAA Closure Devices: US Industry View

Presenter: Mitchell W. Krucoff, Shigeru Saito, Kenneth Stein, MD

October 30, 2016

Presentation TCT 2016

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Presenter: Russell A. Brandwein, Isaac George

October 30, 2016

Presentation TCT 2016

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 30, 2016

Advertisement

TCT 1611: Trialign: Transcatheter Repair of the Tricuspid Valve

Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies

Transcatheter Valve-in-Valve Therapy: Clinical and Technical Pearls

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

How Good Can Surgical Outcomes Be in Secondary MR?

TCT 1600: Minimally Invasive Mitral Valve Replacement With Sapien S3 Valve in a Patient With Severe MAC

Appropriate Use Criteria of LAA Closure Devices: PMDAs View

FDA Perspectives

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples)

Applying Lessons From the CTSN to Clinical Practice

Appropriate Use Criteria of LAA Closure Devices: FDAs View

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension

Appropriate Use Criteria of LAA Closure Devices: US Industry View

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content